GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen

Glaxosmithkline plc (GSK) announced that HHS has placed another order to purchase bulk H5N1 antigen for the U.S. national stockpile of pre-pandemic vaccines.
RTTNews